| Dear Subscriber, |
| Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories. To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y . |
| ADHD News | |
| Data Links Anesthesia Use And Learning Disabilities, ADHD Infants and very young children who are exposed to anesthesia may experience higher rates of learning disabilities and cognitive difficulties than children who are not exposed to anesthesia, according to research and emerging data presented during the SmartTots: Pediatric Anesthesia Neurotoxicity panel at the International Anesthesia Research Society annual meeting in Vancouver, B. | 28 May 2011 |
| Anxiety / Stress News | |
| Good Ward Atmosphere Prevents Stress? Improvements in the ward atmosphere in adult psychiatry can have a positive effect on nursing staff. This is shown in a new dissertation from Malmö University in Sweden.Psychiatry has undergone major changes in the last couple of decades. | 28 May 2011 |
| Arthritis / Rheumatology News | |
| REALISTIC: Certzolimab Delivers In Real World Situations After 12 weeks of treatment certolizumab pegol (Cimzia ®) delivered rapid and consistent improvements in a broad range of rheumatoid arthritis (RA) patients regardless of whether or not they had received prior TNF inhibitors, concluded the latest analysis of the Phase III b REALISTIC trial. | 28 May 2011 |
| Data Presented At Two Global Medical Congresses Reinforce Benefit Of Enbrel® (etanercept) For Patients With Chronic Inflammatory Conditions Amgen (Nasdaq: AMGN) and Pfizer Inc. (NYSE: PFE) announced new results from multiple studies of ENBREL, further expanding the body of evidence supporting the efficacy and safety profile of ENBREL, the most prescribed biologic by rheumatologists in the United States (U. | 28 May 2011 |
| RoActemra Could Change The Current Standard Of Treatment For People Living With Rheumatoid Arthritis Roche announced new data from the ACT-RAY study, presented at the European League Against Rheumatism congress. The results demonstrated that in people with rheumatoid arthritis (RA), RoACTEMRA (tocilizumab, known as ACTEMRA outside Europe) alone had comparable clinical efficacy to RoACTEMRA plus methotrexate (MTX). | 28 May 2011 |
| New Data For Cimzia® (Certolizumab Pegol) Showed A Rapid Clinical Response Across A Broad Population Of Rheumatoid Arthritis (RA) Patients UCB announced data which showed that the addition of Cimzia® (certolizumab pegol) to current therapy was associated with a rapid and consistent clinical response in a diverse group of rheumatoid arthritis (RA) patients. | 28 May 2011 |
| Blood / Hematology News | |
| New Treatment Dissolves Blood Clots In Brain Tissue A new treatment that treats a subset of stroke patients by combining minimally invasive surgery, an imaging technique likened to "GPS for the brain," and the clot-busting drug t-PA appears to be safe and effective, according to a multicenter clinical trial led by Johns Hopkins researchers. | 28 May 2011 |
| Bones / Orthopedics News | |
| Data Presented At Two Global Medical Congresses Reinforce Benefit Of Enbrel® (etanercept) For Patients With Chronic Inflammatory Conditions Amgen (Nasdaq: AMGN) and Pfizer Inc. (NYSE: PFE) announced new results from multiple studies of ENBREL, further expanding the body of evidence supporting the efficacy and safety profile of ENBREL, the most prescribed biologic by rheumatologists in the United States (U. | 28 May 2011 |
| Active Baby Boomers Fuel Demand For Long Lasting Joint Replacements "The number of patients in their 50s coming into my office asking for joint replacement is higher than ever," says Dr. Steven B. Haas, a knee surgeon at Hospital for Special Surgery in New York City. | 28 May 2011 |
| Cancer / Oncology News | |
| Tragara Pharmaceuticals' Apricoxib Reverses EMT, A Key Process For Cancer Progression And Metastasis Tragara Pharmaceuticals, Inc. announced that apricoxib (Capoxigem®, TG01), its novel COX-2 inhibitor in development for select cancer types, demonstrated reversal of the epithelial-mesenchymal transition (EMT) in xenograft models of several types of solid tumors. | 28 May 2011 |
| Cancer Cells Accelerate Aging And Inflammation In The Body To Drive Tumor Growth Researchers at the Kimmel Cancer Center at Jefferson have shed new light on the longstanding conundrum about what makes a tumor grow and how to make it stop. Interestingly, cancer cells accelerate the aging of nearby connective tissue cells to cause inflammation, which ultimately provides "fuel" for the tumor to grow and even metastasize. | 28 May 2011 |
| When Cancer Runs In The Family 5% to 10% of all breast cancers are monogenic in origin. In other words, there is a mutation of the genes BRCA1, BRCA2 or other high-risk genes. In this edition of Deutsches Arzteblatt International (Dtsch Arztebl Int 2011; 108(19): 323 - 30), Alfons Meindl of the Klinikum rechts der Isar (Munich) and coauthors report on new insights into the pathogenesis and treatment of hereditary breast and ovarian cancer and newly-discovered risk genes. | 28 May 2011 |
| Cardiovascular / Cardiology News | |
| Combination Niacin Does Not Improve Heart Attack And Stroke Risk Niacin, also known as vitamin B3, when combined with statin only therapy for patients with heart and vascular disease does not lower heart attack and stroke risk - a finding which made the National Heart, Lung, and Blood Institute and Abbott Laboratories end a clinical trial 18 months early. | 28 May 2011 |
| Boston Scientific Announces Voluntary Recall Of ICross™ Coronary Imaging Catheters Boston Scientific Corporation (NYSE: BSX) announced that it is voluntarily recalling all of its iCross™ Coronary Imaging Catheters used in intravascular ultrasound (IVUS) imaging in patients who are candidates for transluminal coronary interventional procedures. | 28 May 2011 |
| Cholesterol News | |
| Combination Niacin Does Not Improve Heart Attack And Stroke Risk Niacin, also known as vitamin B3, when combined with statin only therapy for patients with heart and vascular disease does not lower heart attack and stroke risk - a finding which made the National Heart, Lung, and Blood Institute and Abbott Laboratories end a clinical trial 18 months early. | 28 May 2011 |
| Clinical Trials / Drug Trials News | |
| RoActemra Could Change The Current Standard Of Treatment For People Living With Rheumatoid Arthritis Roche announced new data from the ACT-RAY study, presented at the European League Against Rheumatism congress. The results demonstrated that in people with rheumatoid arthritis (RA), RoACTEMRA (tocilizumab, known as ACTEMRA outside Europe) alone had comparable clinical efficacy to RoACTEMRA plus methotrexate (MTX). | 28 May 2011 |
| New Data For Cimzia® (Certolizumab Pegol) Showed A Rapid Clinical Response Across A Broad Population Of Rheumatoid Arthritis (RA) Patients UCB announced data which showed that the addition of Cimzia® (certolizumab pegol) to current therapy was associated with a rapid and consistent clinical response in a diverse group of rheumatoid arthritis (RA) patients. | 28 May 2011 |
| Cosmetic Medicine / Plastic Surgery News | |
| Active Baby Boomers Fuel Demand For Long Lasting Joint Replacements "The number of patients in their 50s coming into my office asking for joint replacement is higher than ever," says Dr. Steven B. Haas, a knee surgeon at Hospital for Special Surgery in New York City. | 28 May 2011 |
| Flu / Cold / SARS News | |
| Flu Vaccines Will Be Enough For Half The Population - So Who Should Get Them? While the CDC is advising everyone to get a flu shot, vaccine makers say this is not necessarily true - some people may not need a repeat shot. Whoever is right, even with record production for this coming fall, only half the US population will be able to get vaccinated. | 28 May 2011 |
| GastroIntestinal / Gastroenterology News | |
| FDA Approves Optimer's DIFICID™ (fidaxomicin) Tablets For The Treatment Of Patients With Clostridium Difficile-Associated Diarrhea (CDAD) Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) announced that the U.S. Food and Drug Administration (FDA) has approved the company's antibacterial drug DIFICID™ (fidaxomicin) tablets for the treatment of Clostridium difficile-associated diarrhea (CDAD) in adults 18 years of age and older. | 28 May 2011 |
| FDA Approves Injectable Gel To Treat Fecal Incontinence The U.S. Food and Drug Administration approved a sterile, injectable gel to treat fecal incontinence in patients for whom other therapies such as diet change, fiber therapy or anti-motility medications failed. | 28 May 2011 |
| Genetics News | |
| When Cancer Runs In The Family 5% to 10% of all breast cancers are monogenic in origin. In other words, there is a mutation of the genes BRCA1, BRCA2 or other high-risk genes. In this edition of Deutsches Arzteblatt International (Dtsch Arztebl Int 2011; 108(19): 323 - 30), Alfons Meindl of the Klinikum rechts der Isar (Munich) and coauthors report on new insights into the pathogenesis and treatment of hereditary breast and ovarian cancer and newly-discovered risk genes. | 28 May 2011 |
| Heart Disease News | |
| Combination Niacin Does Not Improve Heart Attack And Stroke Risk Niacin, also known as vitamin B3, when combined with statin only therapy for patients with heart and vascular disease does not lower heart attack and stroke risk - a finding which made the National Heart, Lung, and Blood Institute and Abbott Laboratories end a clinical trial 18 months early. | 28 May 2011 |
| Boston Scientific Announces Voluntary Recall Of ICross™ Coronary Imaging Catheters Boston Scientific Corporation (NYSE: BSX) announced that it is voluntarily recalling all of its iCross™ Coronary Imaging Catheters used in intravascular ultrasound (IVUS) imaging in patients who are candidates for transluminal coronary interventional procedures. | 28 May 2011 |
| HIV / AIDS News | |
| Global Forum On MSM & HIV Encouraged By New PEPFAR Guidance On HIV Prevention For Men Who Have Sex With Men The Global Forum on MSM & HIV (MSMGF) is encouraged by the release of new Technical Guidance on Combination HIV Prevention for men who have sex with men (MSM) from the Office of the U.S. Global AIDS Coordinator (OGAC). | 28 May 2011 |
| Immune System / Vaccines News | |
| Flu Vaccines Will Be Enough For Half The Population - So Who Should Get Them? While the CDC is advising everyone to get a flu shot, vaccine makers say this is not necessarily true - some people may not need a repeat shot. Whoever is right, even with record production for this coming fall, only half the US population will be able to get vaccinated. | 28 May 2011 |
| Infectious Diseases / Bacteria / Viruses News | |
| FDA Approves Optimer's DIFICID™ (fidaxomicin) Tablets For The Treatment Of Patients With Clostridium Difficile-Associated Diarrhea (CDAD) Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) announced that the U.S. Food and Drug Administration (FDA) has approved the company's antibacterial drug DIFICID™ (fidaxomicin) tablets for the treatment of Clostridium difficile-associated diarrhea (CDAD) in adults 18 years of age and older. | 28 May 2011 |
| MRI / PET / Ultrasound News | |
| Boston Scientific Announces Voluntary Recall Of ICross™ Coronary Imaging Catheters Boston Scientific Corporation (NYSE: BSX) announced that it is voluntarily recalling all of its iCross™ Coronary Imaging Catheters used in intravascular ultrasound (IVUS) imaging in patients who are candidates for transluminal coronary interventional procedures. | 28 May 2011 |
| Neurology / Neuroscience News | |
| Brain Circuitry Changes Growing Up Influence Moral Development People's moral responses to similar situations change as they age, according to a new study at the University of Chicago that combined brain scanning, eye-tracking and behavioral measures to understand how the brain responds to morally laden scenarios. | 28 May 2011 |
| Nutrition / Diet News | |
| Food Pyramid Gives Way To Food Plate, USA For the last two decades the federal government has used the Food Pyramid as the basis for good nutritional advice, which never told people how much of which types of foods they should eat. Many also criticized it for not taking into account the impact on insulin of some high carbohydrate foods. | 28 May 2011 |
| Pediatrics / Children's Health News | |
| Data Links Anesthesia Use And Learning Disabilities, ADHD Infants and very young children who are exposed to anesthesia may experience higher rates of learning disabilities and cognitive difficulties than children who are not exposed to anesthesia, according to research and emerging data presented during the SmartTots: Pediatric Anesthesia Neurotoxicity panel at the International Anesthesia Research Society annual meeting in Vancouver, B. | 28 May 2011 |
| Pharma Industry / Biotech Industry News | |
| Actress Jane Seymour's Appeal Generates Over One Million Votes To Help Prevent Atrial Fibrillation-Related Strokes Over one million votes received for projects submitted as part of a global initiative mark the success and worldwide reach of a campaign, initiated by Boehringer Ingelheim, to raise awareness for stroke prevention in atrial fibrillation (AF). | 28 May 2011 |
| Data Presented At Two Global Medical Congresses Reinforce Benefit Of Enbrel® (etanercept) For Patients With Chronic Inflammatory Conditions Amgen (Nasdaq: AMGN) and Pfizer Inc. (NYSE: PFE) announced new results from multiple studies of ENBREL, further expanding the body of evidence supporting the efficacy and safety profile of ENBREL, the most prescribed biologic by rheumatologists in the United States (U. | 28 May 2011 |
| RoActemra Could Change The Current Standard Of Treatment For People Living With Rheumatoid Arthritis Roche announced new data from the ACT-RAY study, presented at the European League Against Rheumatism congress. The results demonstrated that in people with rheumatoid arthritis (RA), RoACTEMRA (tocilizumab, known as ACTEMRA outside Europe) alone had comparable clinical efficacy to RoACTEMRA plus methotrexate (MTX). | 28 May 2011 |
| Tragara Pharmaceuticals' Apricoxib Reverses EMT, A Key Process For Cancer Progression And Metastasis Tragara Pharmaceuticals, Inc. announced that apricoxib (Capoxigem®, TG01), its novel COX-2 inhibitor in development for select cancer types, demonstrated reversal of the epithelial-mesenchymal transition (EMT) in xenograft models of several types of solid tumors. | 28 May 2011 |
| New Data For Cimzia® (Certolizumab Pegol) Showed A Rapid Clinical Response Across A Broad Population Of Rheumatoid Arthritis (RA) Patients UCB announced data which showed that the addition of Cimzia® (certolizumab pegol) to current therapy was associated with a rapid and consistent clinical response in a diverse group of rheumatoid arthritis (RA) patients. | 28 May 2011 |
| Psychology / Psychiatry News | |
| Brain Circuitry Changes Growing Up Influence Moral Development People's moral responses to similar situations change as they age, according to a new study at the University of Chicago that combined brain scanning, eye-tracking and behavioral measures to understand how the brain responds to morally laden scenarios. | 28 May 2011 |
| Data Links Anesthesia Use And Learning Disabilities, ADHD Infants and very young children who are exposed to anesthesia may experience higher rates of learning disabilities and cognitive difficulties than children who are not exposed to anesthesia, according to research and emerging data presented during the SmartTots: Pediatric Anesthesia Neurotoxicity panel at the International Anesthesia Research Society annual meeting in Vancouver, B. | 28 May 2011 |
| Public Health News | |
| Good Ward Atmosphere Prevents Stress? Improvements in the ward atmosphere in adult psychiatry can have a positive effect on nursing staff. This is shown in a new dissertation from Malmö University in Sweden.Psychiatry has undergone major changes in the last couple of decades. | 28 May 2011 |
| Regulatory Affairs / Drug Approvals News | |
| FDA Approves Optimer's DIFICID™ (fidaxomicin) Tablets For The Treatment Of Patients With Clostridium Difficile-Associated Diarrhea (CDAD) Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) announced that the U.S. Food and Drug Administration (FDA) has approved the company's antibacterial drug DIFICID™ (fidaxomicin) tablets for the treatment of Clostridium difficile-associated diarrhea (CDAD) in adults 18 years of age and older. | 28 May 2011 |
| FDA Approves Injectable Gel To Treat Fecal Incontinence The U.S. Food and Drug Administration approved a sterile, injectable gel to treat fecal incontinence in patients for whom other therapies such as diet change, fiber therapy or anti-motility medications failed. | 28 May 2011 |
| Sleep / Sleep Disorders / Insomnia News | |
| 'Sleep On It' Is Sound, Science-Based Advice In recent years, much sleep research has focused on memory, but now results of a new study by University of Massachusetts Amherst psychologist Rebecca Spencer and colleagues suggest another key effect of sleep is facilitating and enhancing complex cognitive skills such as decision-making. | 28 May 2011 |
| Smoking / Quit Smoking News | |
| Age, Gender And Social Advantage Affect Success In Quitting Smoking Where you live, how old you are and whether you're male or female all affect your chances of giving up smoking. These are the findings of a study which suggests that while NHS stop smoking services are effective in supporting some smokers to quit there are significant differences in the longer term success rates for specific groups who are trying to give up smoking. | 28 May 2011 |
| Big Tobacco Scrambles For Smokeless Products With New Bans Looming Big Tobacco is fighting back. In an effort to combat the dramatic increase in taxes, health concerns, smoking bans and stigma in general, companies are venturing into smokeless tobacco and other nicotine products. | 28 May 2011 |
| Plain Tobacco Packaging A Winner With Australians: New Poll New research shows plain packaging of cigarettes is supported by the majority of Australians, despite the tobacco industry's continued attempts to undermine the groundbreaking health initiative. | 28 May 2011 |
| Stroke News | |
| Actress Jane Seymour's Appeal Generates Over One Million Votes To Help Prevent Atrial Fibrillation-Related Strokes Over one million votes received for projects submitted as part of a global initiative mark the success and worldwide reach of a campaign, initiated by Boehringer Ingelheim, to raise awareness for stroke prevention in atrial fibrillation (AF). | 28 May 2011 |
| New Treatment Dissolves Blood Clots In Brain Tissue A new treatment that treats a subset of stroke patients by combining minimally invasive surgery, an imaging technique likened to "GPS for the brain," and the clot-busting drug t-PA appears to be safe and effective, according to a multicenter clinical trial led by Johns Hopkins researchers. | 28 May 2011 |
| Vascular News | |
| New Treatment Dissolves Blood Clots In Brain Tissue A new treatment that treats a subset of stroke patients by combining minimally invasive surgery, an imaging technique likened to "GPS for the brain," and the clot-busting drug t-PA appears to be safe and effective, according to a multicenter clinical trial led by Johns Hopkins researchers. | 28 May 2011 |
| You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y . |
Tidak ada komentar:
Posting Komentar